Sanwar M Mitharwal1, Sandhya Yaddanapudi2, Neerja Bhardwaj1, Vikas Gautam3, Manisha Biswal3, Lakshminarayana Yaddanapudi1. 1. Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India. 2. Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: sandhya.yaddanapudi@gmail.com. 3. Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Abstract
BACKGROUND AND OBJECTIVE: Nosocomial infections are common in intensive care units (ICUs), but the pattern of infections and the distribution of microorganisms vary. We studied the ICU-acquired infections and their effect on patient outcomes in our ICU. METHODS: Patients admitted to our ICU for >48 hours were studied prospectively over a year. Infections were diagnosed based on Centers for Disease Control and Prevention guidelines. Antibiotics were administered based on culture and sensitivity. Univariate and multivariate logistic regressions were carried out to determine the factors associated with infection. RESULTS: One hundred ninety-eight patients were studied. The crude infection rate was 50% with ventilator-associated pneumonia (40%) and bloodstream infection (21%) being the most common. Acinetobacter calcoaceticus-baumannii complex, Pseudomonas aeruginosa, and Klebsiella pneumoniae were the most common microorganisms. More than 90% of patients received antibiotics, the most common being β lactam-β lactamase inhibitors, aminoglycosides, fluoroquinolones, and carbapenems. Thirty-five percent of staphylococci were methicillin-resistant, 50% of Enterococcus strains were vancomycin-resistant, and 68% of Acinetobacter calcoaceticus-baumannii complex, 47% of Pseudomonas strains, and 35% of Klebsiella strains were multidrug-resistant. A longer duration of ventilation was associated with infection. The overall ICU mortality rate was 24% and was similar in patients with or without infection. CONCLUSIONS: The incidence of infection and the multidrug resistance in the ICU was high. Infection was associated with duration of ventilation but not mortality.
BACKGROUND AND OBJECTIVE:Nosocomial infections are common in intensive care units (ICUs), but the pattern of infections and the distribution of microorganisms vary. We studied the ICU-acquired infections and their effect on patient outcomes in our ICU. METHODS:Patients admitted to our ICU for >48 hours were studied prospectively over a year. Infections were diagnosed based on Centers for Disease Control and Prevention guidelines. Antibiotics were administered based on culture and sensitivity. Univariate and multivariate logistic regressions were carried out to determine the factors associated with infection. RESULTS: One hundred ninety-eight patients were studied. The crude infection rate was 50% with ventilator-associated pneumonia (40%) and bloodstream infection (21%) being the most common. Acinetobacter calcoaceticus-baumannii complex, Pseudomonas aeruginosa, and Klebsiella pneumoniae were the most common microorganisms. More than 90% of patients received antibiotics, the most common being β lactam-β lactamase inhibitors, aminoglycosides, fluoroquinolones, and carbapenems. Thirty-five percent of staphylococci were methicillin-resistant, 50% of Enterococcus strains were vancomycin-resistant, and 68% of Acinetobacter calcoaceticus-baumannii complex, 47% of Pseudomonas strains, and 35% of Klebsiella strains were multidrug-resistant. A longer duration of ventilation was associated with infection. The overall ICU mortality rate was 24% and was similar in patients with or without infection. CONCLUSIONS: The incidence of infection and the multidrug resistance in the ICU was high. Infection was associated with duration of ventilation but not mortality.
Authors: E Kousouli; O Zarkotou; L Politi; K Polimeri; G Vrioni; K Themeli-Digalaki; A Tsakris; S Pournaras Journal: Eur J Clin Microbiol Infect Dis Date: 2017-09-06 Impact factor: 3.267
Authors: Antonella Agodi; Martina Barchitta; Annalisa Quattrocchi; Emiliano Spera; Giovanni Gallo; Francesco Auxilia; Silvio Brusaferro; Marcello Mario D'Errico; Maria Teresa Montagna; Cesira Pasquarella; Stefano Tardivo; Ida Mura Journal: PLoS One Date: 2017-09-06 Impact factor: 3.240
Authors: Julien Demiselle; Johann Auchabie; François Beloncle; Philippe Gatault; Steven Grangé; Damien Du Cheyron; Jean Dellamonica; Sonia Boyer; Dimitri Titeca Beauport; Lise Piquilloud; Julien Letheulle; Christophe Guitton; Nicolas Chudeau; Guillaume Geri; François Fourrier; René Robert; Emmanuel Guérot; Julie Boisramé-Helms; Pierre Galichon; Pierre-François Dequin; Alexandre Lautrette; Pierre-Edouard Bollaert; Ferhat Meziani; Loïc Guillevin; Nicolas Lerolle; Jean-François Augusto Journal: Ann Intensive Care Date: 2017-04-05 Impact factor: 6.925
Authors: Yulia Rosa Saharman; Anis Karuniawati; Juliëtte A Severin; Henri A Verbrugh Journal: Antimicrob Resist Infect Control Date: 2021-01-29 Impact factor: 4.887